First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients

Conditions:   Esophageal Cancer;   Pancreas Cancer;   Ovarian Cancer;   Liver Cancer Intervention:   Biological: IL15-transpresenting WT1-targeted Dendritic Cell Vaccine Sponsors:   University Hospital, Antwerp;   Kom Op Tegen Kanker;   Stichting tegen Kanker Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials